Shennon Biotechnologies

Based in the United States, Shennon Biotechnologies is a startup founded in 2021. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Shennon Biotechnologies has developed an ultra-high-throughput profiling engine that analyzes millions of immune cells at the single-cell level to identify rare receptors and targets for developing more effective immunotherapies against solid tumors.